Novavax raised its full-year adjusted revenue forecast on Wednesday, banking on higher sales tied to its vaccine supply ...

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA ...

Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first ...

The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its biomedical research unit.

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

One of the most appealing features of Pfizer's stock is its dividend. The payout recently yielded a hefty 7.4% -- and it's ...

Robert F. Kennedy Jr., the health secretary and a longtime vaccine critic, announced in a statement Tuesday that $500 million ...

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US patients.

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

While Pfizer remains on track for an impressive $7.2 billion in cost cuts by the end of 2027, we think the market is more ...

US stocks end lower after data show higher prices and lower employment. Investors also weigh earnings and Trump tariff threats.